ULTY vs. PPH

Last updated Jun 16, 2026

ULTY (YieldMax Ultra Option Income Strategy ETF) and PPH (VanEck Pharmaceutical ETF) are both exchange-traded funds - ULTY is a Derivative Income fund actively managed by YieldMax, while PPH is a Health & Biotech Equities fund tracking the MVIS US Listed Pharmaceutical 25 Index. ULTY is actively managed, while PPH is passively managed. Over the past year, ULTY returned 7.83% vs 18.69% for PPH. At a 0.18 correlation, their price movements are largely independent. ULTY charges 1.14%/yr vs 0.36%/yr for PPH.

Performance

ULTY vs. PPH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in YieldMax Ultra Option Income Strategy ETF (ULTY) and VanEck Pharmaceutical ETF (PPH). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ULTY achieves a 11.58% return, which is significantly higher than PPH's 2.96% return.

ULTY

• 1D: 2.56%
• 1M: 3.18%
• YTD: 11.58%
• 6M: 13.08%
• 1Y: 7.83%
• 3Y*: —
• 5Y*: —
• 10Y*: —

PPH

• 1D: -1.04%
• 1M: 4.48%
• YTD: 2.96%
• 6M: 3.80%
• 1Y: 18.69%
• 3Y*: 12.38%
• 5Y*: 9.47%
• 10Y*: 8.39%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ULTY vs. PPH - Yearly Performance Comparison

	2026 (YTD)	2025	2024
ULTY YieldMax Ultra Option Income Strategy ETF	11.58%	-0.84%	-4.73%
PPH VanEck Pharmaceutical ETF	2.96%	22.00%	-1.69%

Correlation

The correlation between ULTY and PPH is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.10
Correlation (All Time) Calculated using the full available price history since Feb 29, 2024	0.18

ULTY vs. PPH - Sectors Allocation Comparison

Sectors	ULTY	PPH
Technology	52.3%	-
Basic Materials	12.0%	-
Industrials	10.6%	0.1%
Financial Services	9.8%	-
Communication Services	7.6%	-
Consumer Cyclical	6.6%	-
Healthcare	1.1%	100.0%
Consumer Defensive	0.0%	-
Energy	-	-
Real Estate	-	-
Utilities	-	-

Return for Risk

ULTY vs. PPH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ULTY

ULTY Risk / Return Rank: 14
ULTY Sharpe Ratio Rank: 15
ULTY Sortino Ratio Rank: 14
ULTY Omega Ratio Rank: 14
ULTY Calmar Ratio Rank: 13
ULTY Martin Ratio Rank: 12

PPH

PPH Risk / Return Rank: 34
PPH Sharpe Ratio Rank: 32
PPH Sortino Ratio Rank: 35
PPH Omega Ratio Rank: 31
PPH Calmar Ratio Rank: 38
PPH Martin Ratio Rank: 32

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ULTY vs. PPH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for YieldMax Ultra Option Income Strategy ETF (ULTY) and VanEck Pharmaceutical ETF (PPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ULTY	PPH	Difference
Sharpe ratio: Return per unit of total volatility	0.36	1.07	-0.70
Sortino ratio: Return per unit of downside risk	0.62	1.70	-1.08
Omega ratio: Gain probability vs. loss probability	1.08	1.20	-0.12
Calmar ratio: Return relative to maximum drawdown	0.33	1.74	-1.42
Martin ratio: Return relative to average drawdown	0.63	4.30	-3.67

ULTY vs. PPH - Sharpe Ratio Comparison

The current ULTY Sharpe Ratio is 0.36, which is lower than the PPH Sharpe Ratio of 1.07. The chart below compares the historical Sharpe Ratios of ULTY and PPH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ULTY vs. PPH - Drawdown Comparison

The maximum ULTY drawdown since its inception was -26.85%, smaller than the maximum PPH drawdown of -51.45%. Use the drawdown chart below to compare losses from any high point for ULTY and PPH.

Drawdown Indicators

	ULTY	PPH	Difference
Max Drawdown Largest peak-to-trough decline	-26.85%	-51.45%	+24.60%
Max Drawdown (1Y) Largest decline over 1 year	-24.16%	-10.76%	-13.40%
Max Drawdown (3Y) Largest decline over 3 years	—	-18.06%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-20.26%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-29.70%	—
Current Drawdown Current decline from peak	-8.51%	-4.90%	-3.61%
Average Drawdown Average peak-to-trough decline	-9.89%	-17.29%	+7.40%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.48%	4.45%	+8.03%

Volatility

ULTY vs. PPH - Volatility Comparison

YieldMax Ultra Option Income Strategy ETF (ULTY) has a higher volatility of 8.42% compared to VanEck Pharmaceutical ETF (PPH) at 5.95%. This indicates that ULTY's price experiences larger fluctuations and is considered to be riskier than PPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ULTY	PPH	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.42%	5.95%	+2.47%
Volatility (6M) Calculated over the trailing 6-month period	16.58%	12.18%	+4.40%
Volatility (1Y) Calculated over the trailing 1-year period	21.69%	17.66%	+4.03%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	27.35%	15.14%	+12.21%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.35%	17.00%	+10.35%

ULTY vs. PPH - Expense Ratio Comparison

ULTY has a 1.14% expense ratio, which is higher than PPH's 0.36% expense ratio.

Dividends

ULTY vs. PPH - Dividend Comparison

ULTY's dividend yield for the trailing twelve months is around 110.56%, more than PPH's 2.05% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
PPH VanEck Pharmaceutical ETF	2.05%	1.78%	1.98%	2.09%	1.55%	1.62%	1.66%	1.77%	1.97%	1.92%	2.43%	1.93%
ULTY YieldMax Ultra Option Income Strategy ETF	110.56%	142.99%	111.70%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both ULTY and PPH in my portfolio?

ULTY and PPH have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ULTY or PPH?

ULTY has higher volatility (8.42%) compared to PPH (5.95%). In terms of maximum drawdown, ULTY dropped -26.85% vs PPH's -51.45%.

Which ETF is better, ULTY or PPH?

On 1-year performance, PPH leads with 18.69% vs 7.83% for ULTY. On fees, PPH is cheaper at 0.36% per year. On volatility, PPH has been the lower-risk option at 5.95%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, ULTY or PPH?

Over the 1-year period, PPH has performed better with a 18.69% return vs 7.83%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, ULTY or PPH?

PPH is cheaper with a 0.36% expense ratio, compared with 1.14% for ULTY.

Which ETF pays a higher dividend yield, ULTY or PPH?

ULTY has the higher dividend yield at 110.56%, compared with 2.05% for PPH.

What is the main difference between ULTY and PPH?

ULTY is categorized as Derivative Income, while PPH is Health & Biotech Equities. They also come from different issuers: YieldMax and VanEck. Their fees differ too: 1.14% for ULTY and 0.36% for PPH.

Which has better risk-adjusted returns?

PPH currently has the higher Sharpe Ratio (1.07 vs 0.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.